Table 2 Association of C1orf116 expression in lung and prostate cancer patients
Test group | Wilcoxon rank sum p-value | Bonferroni adjusted p-value |
|---|---|---|
Lung cancer (Director’s Lung Challenge): grade [44] | ||
Grade1 vs Grade 2 | 1.4191e-06 | 3.27E-05 |
Grade 2 vs Grade 3 | 1.1481e-10 | 2.65E-09 |
Grade 1 vs Grade 3 | 2.6121e-17 | 6.00E-16 |
Lung cancer (Director’s Lung Challenge): Smoking Status [44] | ||
Never vs Past | 0.006 | 1.38E-01 |
Past vs Current | 0.006 | 1.38E-01 |
Never vs Current | 0.0002 | 4.60E-03 |
Lung cancer (Okayama): Smoking status [45] | ||
Never smoker vs ever smoker | 0.0586 | 1EÂ +Â 00 |
Prostate cancer (Taylor): Tumor type [46] | ||
Primary vs Metastatic | 0.0340 | 7.82E-01 |